hn.today

Congress can but refuses to fix the antibiotic market

davidngo1562.substack.com13 points4 comments
Screenshot of Congress can but refuses to fix the antibiotic market

Antibiotics face a market failure: new drugs must be held in reserve to slow resistance, so companies cannot earn enough from sales to recover development costs. The contrast between amikacin and plazomicin illustrates the problem. Amikacin, introduced in 1976, became profitable, while Achaogen went bankrupt after spending more than $1 billion developing plazomicin, despite its design to evade resistance enzymes that disable related drugs. By the time a reserve antibiotic is widely needed, its patent may have expired, further weakening the business case. The proposed PASTEUR Act would address this by paying developers through subscriptions rather than tying revenue to how much medicine they sell.

The bill has bipartisan support but remains stalled partly over how to distinguish genuinely valuable drugs from “me-too” products, and partly because Congress has not prioritized it. The argument is that antibiotic superiority should be judged against the resistance mechanisms a drug is built to overcome: plazomicin, for example, outperformed amikacin against bacteria carrying a prevalent enzyme that defeats amikacin. Since patients cannot ethically be deliberately infected with resistant bacteria, animal and laboratory studies should carry substantial weight alongside clinical evidence. Funding standards could reward drugs that defeat common resistance mechanisms and perform at least as well as existing last-resort treatments. The author argues that criteria can be developed with expert input and international examples, and that public pressure is needed to make Congress act before resistant infections become a more acute crisis.

Read on davidngo1562.substack.com4 comments on Hacker News

Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.

More in Science

The daily digest

Today's best Hacker News stories, summarized and screenshotted, one email a day.